COST OF ILLNESS PASIEN KANKER PAYUDARA DI RUMAH SAKIT UMUM PUSAT PROF. Dr. R.D. KANDOU MANADO

Manawan, Fridly (2019) COST OF ILLNESS PASIEN KANKER PAYUDARA DI RUMAH SAKIT UMUM PUSAT PROF. Dr. R.D. KANDOU MANADO. Tesis thesis, Fakultas Farmasi.

	Text BAB 2.pdf Restricted to Registered users only Download (480kB) | Request a copy
	Text BAB 3.pdf Restricted to Registered users only Download (156kB) | Request a copy
	Text BAB 4.pdf Restricted to Registered users only Download (492kB) | Request a copy
	Text BAB 5.pdf Restricted to Registered users only Download (204kB) | Request a copy
	Text BAB 6- LAMPIRAN.pdf Restricted to Registered users only Download (1MB) | Request a copy
	Text COVER-BAB 1.pdf Download (481kB)
	Text INTISARI-ABSTRAK.pdf Download (207kB)
	Text PUBLIKASI.pdf Download (319kB)

Abstract

Breast cancer still became priority concern in developed country, but 69% the dead incident came from developing country. Many of them been diagnose at advance stage, that make treatment and cost more higly. The objectives of this study were to know the burden cost of breast cancer patient in Prof Dr Kandou Medical Center Manado based on hospital perspective, the difference between the real cost and the INA-CBG’s cost, and the key factors that might drive the burden of the real cost of breast cancer. The study was a pharmacoeconomics analys based on hospital perspective to direct medical cost, using non-experimental analysis with cross-sectional design. Data restropectively collect from breast cancer inpatient registered as member of National Health Insurance (JKN) during September 2017-August 2018 period and from financial department of Prof Dr Kandou Medical Center Manado. The sample was used 329 episode of treatment. the data being analyzed using one sample t-test to compare the congruence between the real cost and INA-CBG’s cost. Multivariat linear regression Analysis to find the various predictor factors that might affect on the real cost. The result of the study showed that the average of the real cost per episode of treatment in chemotherapy patient with C-14-3 code was Rp. 13.806.325, treatment in breast procedure with L-1-50 code was Rp. 24.306.626, and treatment for breast tumor with L-4-11 code was Rp. 11.989.772. The difference value between the real cost and INA-CBG’s was Rp. Rp.1.316.865.201 for 183 breast cancer inpatient. The congruence value between the real cost and the INA-CBG’s cost generally significantly different except for C-4-13-II, L-1-50-III and L-4-11-I. Based on multivariat linier regression analysis, severity level, :LOS, and treatment care was the factors that affect the real cost. Keywords: Cost of illness, INA-CBG’s, Breast Cancer, Prof Dr R.D. Kandou Medical Center Hospital Manado

Item Type:	Thesis (Tesis)
Uncontrolled Keywords:	Cost of illness, INA-CBG’s, Breast Cancer, Prof Dr R.D. Kandou Medical Center Hospital Manado
Subjects:	R Medicine > R Medicine (General)
Divisions:	Fakultas Farmasi > Prodi S2 Farmasi
Depositing User:	Mrs NOVI HANDAYANI
Date Deposited:	01 Nov 2019 07:40
Last Modified:	01 Nov 2019 07:40
URI:	http://repo.setiabudi.ac.id/id/eprint/3419

Actions (login required)

View Item